The impact of intensity-modulated radiation treatment on dento-alveolar microvasculature in pharyngeal cancer implant patients.

dental implants head and neck cancer intensity-modulated radiation treatment microvasculature osteoradionecrosis

Journal

Journal of oral rehabilitation
ISSN: 1365-2842
Titre abrégé: J Oral Rehabil
Pays: England
ID NLM: 0433604

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 25 04 2020
revised: 09 07 2020
accepted: 29 07 2020
pubmed: 26 8 2020
medline: 15 12 2020
entrez: 26 8 2020
Statut: ppublish

Résumé

Dental rehabilitation post-radiotherapy often requires the consideration of dental implants. However, these are tentatively prescribed due to the concern of hypovascularisation and possible osteoradionecrosis. Hence, the current study assessed the microvasculature of the dento-alveolar bone at implant sites taking into consideration the exact radiotherapy dose received to the region. Bone cores were taken from nine patients during implant treatment and compared to nine control patients. Specimens were stained using CD31 and digitalised using a high-resolution scanner for qualitative and quantitative assessment of the microvasculature. Monaco A total of 23 bone cores were retrieved for analysis. The cohort had a D Intensity-modulated radiotherapy doses above 30 Gy identified reduction in microvasculature which is a lower threshold than previously accepted. In pharyngeal cancer patients' doses to the jaw bones often exceed this threshold. Coupled with favourable survival in certain oropharyngeal and nasopharyngeal cancer, dental rehabilitation via implants provides a significant clinical challenge.

Identifiants

pubmed: 32841377
doi: 10.1111/joor.13084
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1411-1421

Subventions

Organisme : Royal College of Surgeons of England

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Hawkins PG, Kadam AS, Jackson WC, Eisbruch A. Organ-sparing in radiotherapy for head-and-neck cancer: Improving quality of life. Semin Radiat Oncol. 2018;28(1):46-52.
Ben-David MA, Diamante M, Radawski JD, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68(2):396-402.
Rosenthal DI, Chambers MS, Fuller CD, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;72(3):747-755.
Chang DT, Sandow PR, Morris CG, et al. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck. 2007;29(6):528-536.
Gomez DR, Estilo CL, Wolden SL, et al. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;81(4):e207-e213.
Tsai CJ, Hofstede TM, Sturgis EM, et al. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2013;85(2):415-420.
Gevorgyan A, Wong K, Poon I, Blanas N, Enepekides DJ, Higgins KM. Osteoradionecrosis of the mandible: a case series at a single institution. J Otolaryngol Head Neck Surg. 2013;42(1):46.
Kobayashi W, Teh BG, Kimura H, Kakehata S, Kawaguchi H, Takai Y. Comparison of osteoradionecrosis of the jaw after superselective intra-arterial chemoradiotherapy versus conventional concurrent chemoradiotherapy of oral cancer. J Oral Maxillofac Surg. 2015;73(5):994-1002.
Maesschalck T, Dulguerov N, Caparrotti F, et al. Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy. Head Neck. 2016;38(11):1695-1702.
Beadle BM, Liao KP, Chambers MS, et al. Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: a SEER-Medicare analysis. Head Neck. 2013;35(11):1599-1605.
Bak SY, Qi XS, Kelly JA, et al. Dosimetric distribution to tooth-bearing areas in intensity-modulated radiation therapy for head and neck cancer: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(1):43-48.
Hansen HJ, Maritim B, Bohle GC 3rd, Lee NY, Huryn JM, Estilo CL. Dosimetric distribution to the tooth-bearing regions of the mandible following intensity-modulated radiation therapy for base of tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):e50-e54.
Parahyba CJ, Ynoe Moraes F, Ramos PA, Haddad CM, da Silva JL, Fregnani ER. Radiation dose distribution in the teeth, maxilla, and mandible of patients with oropharyngeal and nasopharyngeal tumors who were treated with intensity-modulated radiotherapy. Head Neck. 2016;38(11):1621-1627.
Cox J. D., & Ang K. K. Chapter 12 The oral cavity. In: Cooper JS, ed. Radiation Oncology E-Book: Rationale, Technique, Results. Elsevier Health Sciences. Within the book Part 3 - Head & Neck. Philadelphia: Mosby; 2003:250-281.
Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983;41(6):351-357.
Delanian S, Lefaix J-L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73(2):119-131.
Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys. 2011;80(3):832-839.
Liu Y, Lim J, Teoh SH. Review: development of clinically relevant scaffolds for vascularised bone tissue engineering. Biotechnol Adv. 2013;31(5):688-705.
Deshpande SS, Donneys A, Farberg AS, Tchanque-Fossuo CN, Felice PA, Buchman SR. Quantification and characterization of radiation-induced changes to mandibular vascularity using micro-computed tomography. Ann Plast Surg. 2014;72(1):100-103.
Fenner M, Park J, Schulz N, et al. Validation of histologic changes induced by external irradiation in mandibular bone. An experimental animal model. J Cranio Maxill Surg. 2010;38(1):47-53.
Xu J, Zheng Z, Fang D, et al. Early-stage pathogenic sequence of jaw osteoradionecrosis in vivo. J Dent Res. 2012;91(7):702-708.
Yachouh J, Breton P, Roux J-P, Goudot P. Osteogenic capacity of vascularised periosteum: an experimental study on mandibular irradiated bone in rabbits. J Plast Reconstr Aesthet Surg. 2010;63(12):2160-2167.
Sønstevold T, Johannessen AC, Stuhr L. A rat model of radiation injury in the mandibular area. Radiat Oncol. 2015;10(1):129.
Poort LJHB, Lie N, Böckmann RA, et al. The histological and histomorphometric changes in the mandible after radiotherapy: an animal model. J Craniomaxillofac Surg. 2017;45(5):716-721.
Bodard A-G, Debbache S, Langonnet S, Laffay F, Fleury B. A model of mandibular irradiation in the rabbit: preliminary results. Bull Group Int Rech Sci Stomatol Odontol. 2013;52(1):17-22.
Bléry P, Espitalier F, Hays A, et al. Development of mandibular osteoradionecrosis in rats: importance of dental extraction. J Cranio Maxill Surg. 2015;43(9):1829-1836.
McGregor AD, MacDonald DG. Post-irradiation changes in the blood vessels of the adult human mandible. Br J Oral Maxillofac Surg. 1995;33(1):15-18.
Veschini L, Crippa L, Dondossola E, Doglioni C, Corti A, Ferrero E. The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization. FASEB J. 2011;25(11):3906-3914.
Arganda-Carreras I, Kaynig V, Rueden C, et al. Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification. Bioinformatics. 2017;33(15):2424-2426.
Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93(3):491-507.
Schoen PJ, Raghoebar GM, Bouma J, et al. Rehabilitation of oral function in head and neck cancer patients after radiotherapy with implant-retained dentures: effects of hyperbaric oxygen therapy. Oral Oncol. 2007;43(4):379-388.
de Barros da Cunha SR, Fonseca FP, Ramos P, Haddad CMK, Fregnani ER, Aranha ACC. Effects of different radiation doses on the microhardness, superficial morphology, and mineral components of human enamel. Arch Oral Biol. 2017;80:130-135.
Garg H, Grewal MS, Rawat S, et al. Dental pulp status of posterior teeth in patients with oral and oropharyngeal cancer treated with concurrent chemoradiotherapy. J Endod. 2015;41(11):1830-1833.
Murdoch-Kinch CA, Kim HM, Vineberg KA, Ship JA, Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(2):373-382.
Marx R, Tursun R. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease. Int J Oral Maxillofac Surg. 2012;41(3):283-289.
Bras J, De Jonge H, Van Merkesteyn J. Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol. 1990;11(4):244-250.
Curi MM, Cardoso CL, De Lima HG, Kowalski LP, Martins MD. Histopathologic and histomorphometric analysis of irradiation injury in bone and the surrounding soft tissues of the jaws. J Oral Maxillofac Surg. 2016;74(1):190-199.
Dekker H, Bravenboer N, van Dijk D, et al. The irradiated human mandible: a quantitative study on bone vascularity. Oral Oncol. 2018;87:126-130.
Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014;50(5):380-386.
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550-4559.
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-4301.
Kasibhatla M, Kirkpatrick JP, Brizel DM. How much radiation is the chemotherapy worth in advanced head and neck cancer? Int J Radiat Oncol Biol Phys. 2007;68(5):1491-1495.
Fowler JF. Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int J Radiat Oncol Biol Phys 2007;68:1491-1495). Int J Radiat Oncol Biol Phys. 2008;71(2):326-329.

Auteurs

Vinod Patel (V)

Oral Surgery Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.

Lucy Di Silvio (L)

King's College London, Centre for Clinical, Oral & Translational Science, Guys Dental Hospital, London, UK.

Jerry Kwok (J)

Oral Surgery Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.

Megan Burns (M)

Oral Surgery Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.

Rhonda Henley Smith (R)

King's Health Partners Head and Neck Cancer Biobank, Guy's & St Thomas' NHS Foundation Trust, London, UK.

Selvam Thavaraj (S)

Department of Head and Neck pathology, King's College London, Centre for Clinical, Oral & Translational Science, Guys Hospital, London, UK.

Lorenzo Veschini (L)

Academic Centre of Reconstructive Science, King's College London, Centre for Clinical, Oral & Translational Science, Guys Dental Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH